May 15, 2025

Advancing MS Care Through Early Intervention and Deeper CNS Insights: Jack P. Antel, MD

The professor of neurology and neurosurgery at McGill University discussed the evolution of multiple sclerosis treatment, the need for earlier intervention, and the pressing scientific questions surrounding neuroinflammation. [WATCH TIME: 4 minutes]

May 15, 2025

Recognizing Scientific Excellence and Impact in Multiple Sclerosis Research: Bruce Bebo, PhD

The executive vice president of research at the National MS Society talked about the significance of the Dystel Prize, honoring researchers in MS whose scientific work has led to meaningful diagnostic or therapeutic advancements. [WATCH TIME: 2 minutes]

May 14, 2025

Progress toward Mitigating Disability Progression in Multiple Sclerosis

New England Journal of Medicine, Volume 392, Issue 19, Page 1966-1968, May 15/22, 2025.

April 8, 2025

Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis

New England Journal of Medicine, Volume 392, Issue 19, Page 1893-1904, May 15/22, 2025.

April 8, 2025

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

New England Journal of Medicine, Volume 392, Issue 19, Page 1883-1892, May 15/22, 2025.